May & Baker Nigeria Plc (NGX: MAYBAKER)

Updated: 5 May 2022

Overview of May & Baker Nigeria Plc

May & Baker Nigeria Plc is a Nigerian company listed on the Nigerian Stock Exchange (NGX) that manufactures and markets a range of pharmaceuticals, vaccines, medical diagnostics, foods and consumer healthcare products.

Today, May & Baker Nigeria Plc’s portfolio of products and services are diversified in more sectors of the Health Care value chain and include the following: the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. May & Baker Nigeria Plc provides pharmaceutical products for anti-diabetics, anti-hypertensive, anti-infectives, anti-malaria, analgesic, cough and cold, multivitamin and anxiolytics. Its anti-diabetic’s products are sold under Diatab and Diamet brands. Its anti-hypertensive products are sold under Cardovasc Retard and Ramitace brands.

The history of May & Baker Nigeria Plc goes back to 1944 when it was first founded, and it had been listed on 10 November 1994.

May & Baker Nigeria Plc has its head offices at 3/5 Sapara Street, Industrial Estate, P M B 21049, Lagos, Nigeria.

The current managing director of May & Baker Nigeria Plc is Patrick O. Ajah.

May & Baker

May & Baker Nigeria Plc's equity stocks are for sale online on the Nigerian Stock Exchange (NGX) under the stock symbol MAYBAKER.

May & Baker Nigeria Plc forms part of the Biotechnology and Drugs Industry and the Health Care Sector of the Nigerian Stock Exchange (NGX).

May & Baker Nigeria Plc Stock Performance

The current price for May & Baker Nigeria Plc stocks on the Nigerian Stock Exchange (NGX) is 4.10 Nigerian Naira (NGN).

An analysis of financial data of May & Baker Nigeria Plc showed that the company has a total market capitalisation of 7.07 Billion NGN, with a Price/Earning ratio of 29.29 and earnings per share of 0.14 NGN.

With an increase of earnings per share and reliable profits over a period, investors who want to buy or sell May & Baker Nigeria Plc stocks can look forward to more profitable dividends and earnings in times to come.

According to an analysis on the live chart of May & Baker Nigeria Plc, analysts forecast further improved performance for the Health Care sector with market share growing as trading volumes increase.

Highlights of May & Baker Nigeria Plc in 2021

May & Baker Nigeria Plc started the current financial year (2021) with a share price of 3.51 Nigerian Naira (NGN) on the Nigerian Stock Exchange (NGX), and it has gained 16.8 % in value on its price valuation, ranking 44th on the NGX with its year-to-date performance.

MAYBAKER however lost 9% of its value in the past four weeks.

May & Baker Nigeria Plc is currently the 75th most-traded stock on the NGX and it has experienced a total trading volume of more than 16 million shares, which were finalised in 950 deals and were valued at a total of 70.3 million Nigerian Naira (NGN) over the recent three month period from September to December 2021, with an average of 253,452 shares in each trading session.

During the same period a volume high of 1.45 million was achieved on September 30.

May & Baker - How To Trade

How to buy May & Baker Nigeria Plc stocks – Step by Step

The stock market is one of the most attractive financial markets that sees millions of retail investors and traders participating daily. To buy, sell or trade May & Baker Nigeria Plc stocks on the Nigerian Stock Exchange (NGX), traders and investors can follow a few simple steps:

  1. Find the share that you want to buy, in this case, “MAYBAKER”.
  2. Select a forex broker that offers access to the Nigerian Stock Exchange (NGX).
  3. Review the broker's trading conditions, fees, deposit and withdrawal methods, trading platform, customer support, regulation, and other components to ensure that they are aligned with your trading plan.
  4. Open a live trading account with the broker by completing the online application form and providing the necessary documentation to verify the trading account.
  5. Once your account has been activated, you are ready to make your first share purchase through the broker.
  6. From here you can start to build and diversify your portfolio by buying more shares.

FAQs

The Nigerian Stock Exchange (NGX) (officially the Nigerian Exchange Group) is a leading integrated market organisation in Africa servicing the continent’s largest economy, that of Nigeria. The Exchange provides capital access to companies that seek to take advantage of the financial markets to fund their business expansion. The NGX also provides its collection of domestic, regional, and international investors with an array of regulated securities to achieve their investment objectives.

The NGX publishes the benchmark, value-weighted All-Share Index (ASI), formulated in January 1984 with a base value of 100 and which tracks the general market movement of all listed equities on the Exchange.

The NGX30 and NGX50 are additional indices that track the top 30 and 50 companies in terms of market capitalization and liquidity respectively. Only fully paid-up common shares weighted by adjusted market capitalization are admitted to these indices.

In March 2021, the Nigerian Stock Exchange was transformed into a shareholder-owned, profit making entity, the Nigerian Exchange Group Plc, when it was demutualised from a member-owned not-for-profit entity.

May & Baker Nigeria Plc trades its equity on the Nigerian Stock Exchange (NGX) under the stock symbol MAYBAKER.

May & Baker Nigeria Plc is a Nigerian company listed on the Nigerian Stock Exchange (NGX) that manufactures and markets a range of pharmaceuticals, vaccines, medical diagnostics, foods and consumer healthcare products.

May & Baker Nigeria Plc forms part of the Biotechnology and Drugs Industry and the Health Care Sector of the Nigerian Stock Exchange (NGX).

At the time of writing, the last available or current price of May & Baker Nigeria Plc shares was 4.10 NGN on the Nigerian Stock Exchange (NGX).

May & Baker Nigeria Plc’s forecast indicates further growth and improvement in the next quarter of 2021, with investors expecting lucrative dividends and returns with increased financial performance.

The Year to date change in the stock price of May & Baker Nigeria Plc is 16.8 %.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .